Elsevier Coronavirus Research HubElsevier invites researchers and data scientists focused on Coronavirus vaccine, drug, clinical and other related research, to freely access these Elsevier solutions for their work. Elsevier coronavirus and Covid-19 related full text articles and chapters will be provided for as long as needed while the public health emergency is ongoing. Research tools and selected Virology and Infectious Disease Journals are open to coronavirus researchers through 28th of October 2020.